Literature DB >> 18046317

The phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity.

H Kuwana1, Y Terada, T Kobayashi, T Okado, J M Penninger, J Irie-Sasaki, T Sasaki, S Sasaki.   

Abstract

Nephrotoxicity is a frequent complication of cisplatin-based chemotherapy often limiting its use. In this study, we attempted to the role of the phosphoinositide-3 kinase (PI3K)-gamma-Akt pathway in this form of acute kidney injury. Using PI3K-gamma knockout mice, we found that a conventional dose of cisplatin was more lethal in the knockout mice where the blood urea nitrogen and serum creatinine were significantly higher in them than in wild-type mice. Phosphorylation of Akt in the renal tubules was abrogated in the knockout mice with the severity of renal dysfunction and numbers of TUNEL (terminal deoxynucleotidyl transferase (TdT) mediated nick-end labeling)-positive renal tubule cells being higher in the knockout than in wild-type mice. Cisplatin treatment significantly increased. Caspase-3 activity, histone-associated DNA fragments, and number of annexin V-positive cells was significantly higher in cisplatin-treated primary cultured renal tubular epithelial cells of knockout mice. Transfection of dominant-active forms of Akt and PI3K-gamma ameliorated apoptosis of the tubule epithelial cells derived from the knockout mice. Our results suggest that the PI3K-gamma-Akt pathway lessens apoptosis and plays a critical role in the maintenance of renal function in cisplatin-induced acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046317     DOI: 10.1038/sj.ki.5002702

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  24 in total

1.  Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Authors:  Navjotsingh Pabla; Guie Dong; Man Jiang; Shuang Huang; M Vijay Kumar; Robert O Messing; Zheng Dong
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  Phosphorylation mechanisms in intensive care medicine.

Authors:  Erica L Martin; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-09-04       Impact factor: 17.440

3.  Disruption of gap junctions attenuates aminoglycoside-elicited renal tubular cell injury.

Authors:  Jian Yao; Tao Huang; Xin Fang; Yuan Chi; Ying Zhu; Yigang Wan; Hiroyuki Matsue; Masanori Kitamura
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Human amniotic fluid stem cell preconditioning improves their regenerative potential.

Authors:  Cinzia Rota; Barbara Imberti; Michela Pozzobon; Martina Piccoli; Paolo De Coppi; Anthony Atala; Elena Gagliardini; Christodoulos Xinaris; Valentina Benedetti; Aline S C Fabricio; Elisa Squarcina; Mauro Abbate; Ariela Benigni; Giuseppe Remuzzi; Marina Morigi
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

5.  Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.

Authors:  Mingjun Shi; Brianna Flores; Peng Li; Nancy Gillings; Kathryn L McMillan; Jianfeng Ye; Lily Jun-Shen Huang; Sachdev S Sidhu; Yong-Ping Zhong; Maria T Grompe; Philip R Streeter; Orson W Moe; Ming Chang Hu
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

6.  EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injury.

Authors:  Song He; Na Liu; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-19

7.  Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo.

Authors:  Kosuke Inoue; Hitoshi Kuwana; Yoshiko Shimamura; Koji Ogata; Yoshinori Taniguchi; Toru Kagawa; Taro Horino; Toshihiro Takao; Tatsuhito Morita; Sei Sasaki; Noboru Mizushima; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2009-12-15       Impact factor: 2.801

8.  Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase.

Authors:  Alan R Parrish; Gang Chen; Robert C Burghardt; Takaho Watanabe; Christophe Morisseau; Bruce D Hammock
Journal:  Cell Biol Toxicol       Date:  2008-04-03       Impact factor: 6.691

9.  Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury.

Authors:  Jinhua Tang; Na Liu; Evelyn Tolbert; Murugavel Ponnusamy; Li Ma; Rujun Gong; George Bayliss; Haidong Yan; Shougang Zhuang
Journal:  Am J Pathol       Date:  2013-05-15       Impact factor: 4.307

10.  Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity.

Authors:  Zhixia Song; Jiefu Zhu; Qingqing Wei; Guie Dong; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.